176 related articles for article (PubMed ID: 16392809)
1. Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents.
Briseño-Roa L; Hill J; Notman S; Sellers D; Smith AP; Timperley CM; Wetherell J; Williams NH; Williams GR; Fersht AR; Griffiths AD
J Med Chem; 2006 Jan; 49(1):246-55. PubMed ID: 16392809
[TBL] [Abstract][Full Text] [Related]
2. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
[TBL] [Abstract][Full Text] [Related]
3. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.
Bigley AN; Harvey SP; Narindoshvili T; Raushel FM
Biochemistry; 2021 Sep; 60(38):2875-2887. PubMed ID: 34494832
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
[TBL] [Abstract][Full Text] [Related]
5. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
8. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
10. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay.
Wille T; Tenberken O; Reiter G; Müller S; Le Provost R; Lafont O; Estour F; Thiermann H; Worek F
Toxicology; 2009 Nov; 265(3):96-100. PubMed ID: 19800384
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
12. Enzymes for the homeland defense: optimizing phosphotriesterase for the hydrolysis of organophosphate nerve agents.
Tsai PC; Fox N; Bigley AN; Harvey SP; Barondeau DP; Raushel FM
Biochemistry; 2012 Aug; 51(32):6463-75. PubMed ID: 22809162
[TBL] [Abstract][Full Text] [Related]
13. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
[TBL] [Abstract][Full Text] [Related]
14. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking, Metal Substitution and Hydrolysis Reaction of Chiral Substrates of Phosphotriesterase.
de Castro AA; Caetano MS; Silva TC; Mancini DT; Rocha EP; da Cunha EF; Ramalho TC
Comb Chem High Throughput Screen; 2016; 19(4):334-44. PubMed ID: 27012528
[TBL] [Abstract][Full Text] [Related]
16. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
17. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase.
Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H
Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823
[TBL] [Abstract][Full Text] [Related]
18. Post-VX exposure treatment of rats with engineered phosphotriesterases.
Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
[TBL] [Abstract][Full Text] [Related]
19. Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.
Ashani Y; Gupta RD; Goldsmith M; Silman I; Sussman JL; Tawfik DS; Leader H
Chem Biol Interact; 2010 Sep; 187(1-3):362-9. PubMed ID: 20303930
[TBL] [Abstract][Full Text] [Related]
20. Structural and kinetic evidence of aging after organophosphate inhibition of human Cathepsin A.
Bouknight KD; Jurkouich KM; Compton JR; Khavrutskii IV; Guelta MA; Harvey SP; Legler PM
Biochem Pharmacol; 2020 Jul; 177():113980. PubMed ID: 32305437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
